Consequently, the use of prostate-specific antigen (PSA) analysis, due to its low specificity for PCa, would adversely impact overdiagnosis, overtreatment, and unnecessary biopsies [10]. The gene discussed is KLK3; the disease is posterior cortical atrophy.